Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.88−0.03 (-3.52%)
Close on Nov 13, 2026Market cap $7.06MP/E –Yield –
Immuron total assets
Total assets on the balance sheet at the end of each period.
Immuron's total assets was A$13.15M at Jun 30, 2026. For fiscal 2026 it was A$13.15M, up 29.8% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is A$27.05M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$13.15M | +29.8% |
| FY2025 | Jun 30, 2025 | A$10.13M | -34.9% |
| FY2024 | Jun 30, 2024 | A$15.55M | -29.3% |
| FY2023 | Jun 30, 2023 | A$21.99M | -11.5% |
| FY2022 | Jun 30, 2022 | A$24.86M | -8.1% |
| FY2021 | Jun 30, 2021 | A$27.05M | +336.2% |
| FY2020 | Jun 30, 2020 | A$6.20M | -27.6% |
| FY2019 | Jun 30, 2019 | A$8.56M | -7.4% |
| FY2018 | Jun 30, 2018 | A$9.24M | +11.5% |
| FY2017 | Jun 30, 2017 | A$8.29M | -6.1% |
| FY2016 | Jun 30, 2016 | A$8.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$13.15M | -47.1% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$10.13M | -62.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$15.55M | +150.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$21.99M | +156.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$24.86M | +168.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$27.05M | +226.5% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$6.20M | -29.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$8.56M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$9.24M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$8.29M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | A$8.83M | – |
See a number that looks wrong?